Daniel C. Martin
Daniel C. Martin is Chief Commercial Officer of Deciphera Pharmaceuticals, Inc.
In the past Mr. Martin occupied the position of Vice President-Marketing & Market Access at Heron Therapeutics, Inc.
Mr. Martin received an undergraduate degree from the University of Virginia and an MBA from The Wharton School of the University of Pennsylvania.
|02/16/2022||1,146||Disposition at $9.05 per share.||10,372|
|01/18/2022||13,667||Award at $0 per share.||0|
|12/15/2021||8,300||Award at $0 per share.||0|
|01/22/2020||26,999||Disposition at $67.18 per share.||1,813,793|
|01/22/2020||26,999||Derivative/Non-derivative trans. at $36.1 per share.||974,663|
|09/19/2019||3,000||Disposition at $35.56 per share.||106,680|
|09/18/2018||20,000||Award at $0 per share.||0|